Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Oliver Sartor MD
Oliver Sartor MD Advisory Board
Roxana Dronca MD
Roxana S. Dronca MD Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · August 05, 2024

Nivolumab With or Without Ipilimumab Plus SBRT for Metastatic Biliary Tract Cancer

Clinical Cancer Research

 

 Save  Recommend
 Share

Additional Info

Clinical Cancer Research
Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
Clin. Cancer Res 2024 Jun 14;[EPub Ahead of Print], A Markussen, JS Johansen, FO Larsen, S Theile, JP Hasselby, GL Willemoe, T Lorentzen, K Madsen, E Høgdall, TS Poulsen, EE Wilken, P Geertsen, CP Behrens, IM Svane, D Nielsen, IM Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated